The five-day meeting in Geneva focused on developing the Pathogen Access and Benefit-Sharing (PABS) annex to the WHO Pandemic Agreement, with governments working towards a system that is practical, equitable and feasible to implement.
The solution will process more than 60 million documents annually and support faster access to services for more than three million Daman members across the UAE.
Launched at the World Health Assembly in 2025, Aira addresses three challenges facing primary healthcare: staff shortages, inconsistent use of clinical guidelines and the administrative workload that limits the time health workers spend with patients.
CT Coronary Angiography is a non invasive imaging procedure that uses CT technology to produce detailed images of the coronary arteries, the blood vessels that supply the heart with blood.
The proposed expansion would allow its use in adolescents aged 12 to 17 years with moderate to severe chronic hand eczema (CHE) when topical corticosteroids are inadequate or inappropriate.
Under the agreement, 1ST Biotherapeutics will receive US$1.8 million upfront and an additional US$1.8 million payment in the near term.
The projects form part of Reckitt’s broader effort to increase production and bring research activities closer to its U.S. commercial operations.
Roche will take responsibility for subsequent development activities, including preclinical research, and oversee the programmes as they progress towards potential commercialisation.
The new company combines Kincell’s expertise in immune-cell technologies with Cellipont’s experience in stem cells, induced pluripotent stem cells (iPSCs), mesenchymal stromal cells (MSCs), dendritic cells, exosomes and emerging messenger RNA (mRNA) technologies.
The organisations will identify key markets and medical travel corridors, particularly across Africa, Asia and the Middle East, and develop travel solutions that address the needs of patients, referring physicians, insurers and employers.